Article
Clinical utility of ABCB1 and ABCG2 genotyping for assessing the clinical and pathological response to FAC therapy in Mexican breast cancer patients.
Cancer chemotherapy and pharmacology - 1 Jun 2021
Turiján-Espinoza Eneida, Ruíz-Rodríguez Víctor Manuel, Uresti-Rivera Edith Elena, Martínez-Leija Ernesto, Zermeño-Nava José de Jesús, Guel-Pañola Arturo, Romano-Moreno Silvia, Vargas-Morales Juan Manuel, Portales-Pérez Diana Patricia
Abstract excerpt
PURPOSE: Resistance to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) in some patients with locally advanced breast cancer remains one of the main obstacles to first-line treatment. We investigated clinical and pathological responses to FAC neoadjuvant chemotherapy in Mexican women with breast cancer and their possible association with SNPs present in ABC transporters as...
Topics
Join the communities discussing this publication.
